Normal view MARC view

Entry Corporate Name

Number of records used in: 1

001 - CONTROL NUMBER

  • control field: 4866

003 - CONTROL NUMBER IDENTIFIER

  • control field: EG-CaNGU

005 - DATE AND TIME OF LATEST TRANSACTION

  • control field: 20230117141450.0

008 - FIXED-LENGTH DATA ELEMENTS

  • fixed length control field: 850626nn azannaabn a ana d

040 ## - CATALOGING SOURCE

  • Original cataloging agency: DNLM
  • Language of cataloging: eng
  • Description conventions: rda
  • Transcribing agency: DLC
  • Modifying agency: DLC
  • Modifying agency: OCoLC
  • Modifying agency: NjP
  • Modifying agency: EG-CaNGU

046 ## - SPECIAL CODED DATES

  • End period: 1998
  • Source of date scheme: edtf

110 2# - HEADING--CORPORATE NAME

  • Corporate name or jurisdiction name as entry element: Boehringer Mannheim GmbH.
  • Subordinate unit: Biochemical Department

370 ## - ASSOCIATED PLACE

  • Associated country: Mannheim (Germany)
  • Source of term: naf

510 2# - SEE ALSO FROM TRACING--CORPORATE NAME

  • Control subfield: r
  • Relationship information: Successor :
  • Corporate name or jurisdiction name as entry element: Roche Diagnostics

670 ## - SOURCE DATA FOUND

  • Source citation: Clinical aspects of fibrinolysis and thrombolysis, 1983:
  • Information found: p. 3 (Boehringer Mannheim)

670 ## - SOURCE DATA FOUND

  • Source citation: LC/NLM files, 5/3/85
  • Information found: (hdg.: Boehringer Mannheim GmbH; usage: Boehringer Mannheim GmbH, Boehringer Mannheim ; place of pub., Mannheim, Germany)

670 ## - SOURCE DATA FOUND

  • Source citation: Roche diagnostics WWW site, October 5, 2017
  • Information found: (Roche Diagnostics acquired Boehringer Mannheim in 1998)

670 ## - SOURCE DATA FOUND

  • Source citation: Wikipedia WWW site, Oct. 5, 2017 (After acquisition by Roche Diagnostics, the name Boehringer Mannheim was no longer used)